Halper Sadeh LLC is investigating whether certain officers and directors of Humana Inc. breached their fiduciary duties to shareholders. Long-term Humana shareholders may be eligible to seek corporate governance reforms, financial incentives, or other relief. The firm encourages shareholders to contact them promptly as there may be limited time to enforce rights. This investigation aims to improve company oversight and protect shareholder value.
Humana Inc. shares are currently priced at USD 423.49 on Pluang, showing a 2.31% decline in the last day. The stock has a market cap of $52.05 billion and a dividend yield of 0.82%. As of Oct 14, 2026 02:22 WIB, most Pluang users are buying the stock, with 83% of order activity favoring buys over sells.
UnitedHealth shares rose 4% after beating Q3 2026 earnings estimates with adjusted EPS of $4.69 and raising its full-year outlook to at least $20.50. The earnings beat was driven by improved medical care ratio, helped partly by a $610 million reserve...
Humana's stock surged after its main Medicare Advantage plan regained a 4-star rating for 2027 from the Centers for Medicare and Medicaid Services, up from 3.5 stars in 2026. This upgrade means 95% of Humana's Medicare Advantage members will be in pl...
Oppenheimer upgraded Humana's price target from $405 to $475, citing strong performance in Medicare Advantage plans where 95% of members are in four-star or higher rated plans. This upgrade implies a potential 22.7% upside from Humana's current stock...
The Centers for Medicare & Medicaid Services (CMS) announced an 18% drop in Medicare Advantage contracts rated four stars or higher for 2027, due to changes in rating criteria including new medication-safety measures and increased weight on physical ...
Humana's shares rose nearly 15% after the company improved its Medicare Advantage quality ratings for 2027, with about 95% of members enrolled in plans rated at least four stars. The company now has 18 contracts rated four stars or higher, including ...
